Can-Fite BioPharma Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Can-Fite BioPharma Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q4 2023.
  • Can-Fite BioPharma Ltd. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $52K, a 38.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $52K -$32K -38.1% Dec 31, 2023 20-F 2024-03-28
Q2 2023 $87K -$24K -21.6% Jun 30, 2023 6-K 2023-08-31
Q4 2022 $84K -$54K -39.1% Dec 31, 2022 20-F 2024-03-28
Q2 2022 $111K +$34K +44.2% Jun 30, 2022 6-K 2022-08-25
Q4 2021 $138K +$65K +89% Dec 31, 2021 20-F 2023-03-30
Q2 2021 $77K +$11K +16.7% Jun 30, 2021 6-K 2021-08-26
Q4 2020 $73K -$9K -11% Dec 31, 2020 20-F 2022-03-24
Q2 2020 $66K Jun 30, 2020 6-K 2020-08-27
Q4 2019 $82K Dec 31, 2019 20-F 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.